Published in Telemedicine Business Week, March 10th, 2004
"We are very pleased to have Tim and Dennis join our team. With proven track records of success, including numerous allowed INDs [investigational new drug applications] and marketing approvals between them, their expertise in both therapeutics and imaging will be invaluable to our R&D efforts," said Robert Beardsley, PhD, CEO of Kereos. "These new hires...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.